EUVIMEDEUVIMED entdecken
VergleichsstudieValidierungsstudie

Comparison and validation of systemic immune-inflammation index, C-reactive protein/albumin ratio, and C-reactive protein-albumin-lymphocyte index for assessing disease activity in rheumatoid arthritis

Xiang-Mei Kang, Pin-Chao Hu, Zhen-Yi Long, Yi Chen, Hao Yuan

Clinical Rheumatology · 2026-11 · 45 (11) · 6555-6571

DOI: 10.1007/s10067-026-08424-0 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Clinical Rheumatology, online erschienen am 25.09.2026. Verfasst von Xiang-Mei Kang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, 410005, Pe…. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, C-Reactive Protein, Serum Albumin, Inflammation. Die Arbeit nennt 41 Literaturangaben. Gefördert von: Natural Science Foundation of the Hunan Provincial Department of Science and Technology, Key Project of the Hunan Provincial Health Commission, Key Cultivation Project of the Renshu Fund of the Hunan Provincial People's Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: This study explored the value of the systemic immune-inflammation index (SII), C-reactive protein/albumin ratio (CAR), and C-reactive protein-albumin-lymphocyte index (CALLY) to evaluate rheumatoid arthritis (RA) activity and guide clinical decision-making. METHOD: We analyzed the levels of SII, CAR, and CALLY in 280 participants (180 RA patients as the training cohort and 100 healthy controls) and compared the differences between RA groups and their correlations with the Disease Activity Score-28 (DAS28), Erythrocyte Sedimentation Rate (ESR), and C-reactive protein (CRP) levels. Another 83 patients (stratified by disease activity into three subgroups: 21, 37, and 25 patients) formed the time validation cohort, and the area under the curve (AUC) differences were compared between the training and validation cohorts. The model performance was evaluated using calibration curves and decision curve analysis. RESULTS: SII and CAR levels were significantly higher in the RA group than in the healthy control group, whereas CALLY levels were significantly lower (P < 0.05). CAR was positively correlated with DAS28-ESR (r = 0.605), whereas CALLY was negatively correlated with DAS28-ESR (r = - 0.575). Correlation analyses revealed near-perfect collinearity of CAR and CALLY with CRP (r = 0.996 and r = - 0.966, respectively). CALLY exhibited an independent predictive value after controlling for CRP levels. Receiver operating characteristic curve analyses revealed that all models yielded relatively high AUC values without statistically significant differences. Calibration and decision curve analyses revealed that the SII + CAR model provided a more stable calibration performance and net benefit. CONCLUSIONS: Overall, CALLY serves as an independent predictor of RA disease activity and provides a clinically meaningful assessment of patients nutritional status and immune reserves. SII + CAR has more practical application value in terms of calibration performance and net clinical benefit. Multicenter prospective studies with long-term follow-up are required to validate its stability and clinical utility. Key Points • Biological markers for assessing RA disease activity, systematic comparative and validation studies, and guidance for clinical decision-making analyses remain to be identified. • We evaluated the performance of the SII, CAR, and CALLY in assessing RA disease activity using ROC, calibration, and decision curve analyses. • CALLY serves as an independent predictor of RA disease activity, and SII + CAR has greater practical value in terms of discriminatory ability, calibration performance, and net clinical benefit.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidC-Reactive ProteinSerum AlbuminInflammationLymphocytesHumansFemaleMaleMiddle AgedSeverity of Illness IndexAdultBiomarkersBlood SedimentationAgedROC CurveCase-Control StudiesArea Under Curve

Stichwörter der Autor:innen

C-reactive protein-albumin-lymphocyte indexC-reactive protein/albumin ratioDisease activityRheumatoid arthritisSystemic immune-inflammation index

Substanzen

C-Reactive ProteinBiomarkersSerum Albumin

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, 410005, People's Republic of China.
  • Department of Clinical Laboratory, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, 410005, People's Republic of China. yuanhao666@hunnu.edu.cn.

Förderung

  • Natural Science Foundation of the Hunan Provincial Department of Science and Technology
  • Key Project of the Hunan Provincial Health Commission
  • Key Cultivation Project of the Renshu Fund of the Hunan Provincial People's Hospital
  • Natural Science Foundation of the Changsha Science and Technology Bureau
  • Key Cultivation Project of the Renshu Fund of the Hunan Provincial People’s Hospital

Zitieren

APA

Kang, X. M., Hu, P. C., Long, Z. Y., Chen, Y., & Yuan, H. (2026). Comparison and validation of systemic immune-inflammation index, C-reactive protein/albumin ratio, and C-reactive protein-albumin-lymphocyte index for assessing disease activity in rheumatoid arthritis. Clinical Rheumatology, 45(11), 6555-6571. https://doi.org/10.1007/s10067-026-08424-0

Vancouver

Kang XM, Hu PC, Long ZY, Chen Y, Yuan H. Comparison and validation of systemic immune-inflammation index, C-reactive protein/albumin ratio, and C-reactive protein-albumin-lymphocyte index for assessing disease activity in rheumatoid arthritis. Clinical Rheumatology. 2026;45(11):6555-6571. doi:10.1007/s10067-026-08424-0

BibTeX
@article{Kang2026,
  author = {Kang, Xiang-Mei and Hu, Pin-Chao and Long, Zhen-Yi and Chen, Yi and Yuan, Hao},
  title = {Comparison and validation of systemic immune-inflammation index, C-reactive protein/albumin ratio, and C-reactive protein-albumin-lymphocyte index for assessing disease activity in rheumatoid arthritis},
  journal = {Clinical Rheumatology},
  year = {2026},
  volume = {45},
  number = {11},
  pages = {6555--6571},
  doi = {10.1007/s10067-026-08424-0}
}
Kostenlos starten →